Dingemanse J
Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pharm World Sci. 1995 May 26;17(3):67-75. doi: 10.1007/BF01875434.
Insomnia is a complex complaint which is often multifactorial in origin. Pharmacotherapy can only be an adjunct in the treatment of insomnia and hypnotics should be given on an intermittent basis for short periods of time. An overview is presented of the currently available hypnotics, of which benzodiazepines are still the most widely prescribed. New drugs which bind to specific receptor subtypes or which are partial benzodiazepine receptor agonists might overcome the disadvantages associated with chronic benzodiazepine use, but more long-term investigations are needed.
失眠是一种复杂的主诉,其病因往往是多因素的。药物治疗只能作为失眠治疗的辅助手段,催眠药应间歇性、短时间使用。本文概述了目前可用的催眠药,其中苯二氮䓬类药物仍是处方最广泛的。与特定受体亚型结合的新药或部分苯二氮䓬受体激动剂可能会克服长期使用苯二氮䓬类药物带来的缺点,但还需要更多的长期研究。